0001958244-24-001060.txt : 20240304 0001958244-24-001060.hdr.sgml : 20240304 20240304165500 ACCESSION NUMBER: 0001958244-24-001060 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 24715519 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MUSSALLEM MICHAEL A CENTRAL INDEX KEY: 0001204551 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORP STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 144 1 primary_doc.xml 144 0001204551 XXXXXXXX LIVE 0001099800 Edwards Lifesciences Corporation 001-15525 1 Edwards Way Irvine CA 92614 1-949-250-2500 Michael A. Mussallem Other: Former CEO Common Goldman Sachs & Co. LLC 200 West Street New York NY 10282 88050 7662111 601300000 03/04/2024 NYSE Common 05/11/2017 Acquired as compensation -- Stock Options Issuer N 88050 05/11/2017 Compensation -- Cashless exercise / same-day sale N Mussallem Living Trust dtd 03/07/2005 1 Edwards Way Irvine CA 92614 Common 01/05/2024 29350 2141963 Mussallem Living Trust dtd 03/07/2005 1 Edwards Way Irvine CA 92614 Common 02/05/2024 29350 2567538 The sales of shares set forth herein are made in connection with a selling plan dated 2/15/2023, that is intended to comply with Rule 10b5-1(c). Shares to be sold by Mussallem Living Trust dtd 03/07/2005. 03/04/2024 02/15/2023 Goldman Sachs & Co. LLC on behalf of Michael A. Mussallem